EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis

Aravind Ganesh iD, Benjamin Beland, Gordon A E Jewett iD, David J T Campbell, Malavika Varma, Ravinder-Jeet Singh iD, Abdulaziz Al-Sultan, John H Wong iD, Bijoy K Menon

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2024

DOI: 10.1017/cjn.2023.28 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024. Verfasst von Aravind Ganesh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Carotid Stenosis, Endarterectomy, Carotid, Physicians, Stroke. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whereas the beneficial effect of antiplatelet therapy for recurrent stroke prevention has been well established, uncertainties remain regarding the optimal antithrombotic regimen for recently symptomatic carotid stenosis. We sought to explore the approaches of stroke physicians to antithrombotic management of patients with symptomatic carotid stenosis.

Methods

We employed a qualitative descriptive methodology to explore the decision-making approaches and opinions of physicians regarding antithrombotic regimens for symptomatic carotid stenosis. We conducted semi-structured interviews with a purposive sample of 22 stroke physicians (11 neurologists, 3 geriatricians, 5 interventional-neuroradiologists, and 3 neurosurgeons) from 16 centers on four continents to discuss symptomatic carotid stenosis management. We then conducted thematic analysis on the transcripts.

Results

Important themes revealed from our analysis included limitations of existing clinical trial evidence, competing surgeon versus neurologist/internist preferences, and the choice of antiplatelet therapy while awaiting revascularization. There was a greater concern for adverse events while using multiple antiplatelet agents (e.g., dual-antiplatelet therapy (DAPT)) in patients undergoing carotid endarterectomy compared to carotid artery stenting. Regional variations included more frequent use of single antiplatelet agents among European participants. Areas of uncertainty included antithrombotic management if already on an antiplatelet agent, implications of nonstenotic features of carotid disease, the role of newer antiplatelet agents or anticoagulants, platelet aggregation testing, and timing of DAPT.

Conclusion

Our qualitative findings can help physicians critically examine the rationale underlying their own antithrombotic approaches to symptomatic carotid stenosis. Future clinical trials may wish to accommodate identified variations in practice patterns and areas of uncertainty to better inform clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carotid StenosisEndarterectomy, CarotidPhysiciansStrokeHumansFibrinolytic AgentsPlatelet Aggregation InhibitorsRisk FactorsStentsTreatment OutcomeClinical Trials as Topic

Stichwörter der Autor:innen

AntiplateletAntithrombotic medicationCarotid stenosisEquipoiseStrokeTransient ischemic attack

Substanzen

Fibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
  • Department of Community Health Sciences, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • The Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
  • Departments of Medicine and Cardiac Sciences, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Department of Emergency Medicine, University of Calgary Cumming School of Medicine, Calgary, Canada.
  • Northern Ontario School of Medicine, Sudbury, Ontario, Canada.

ORCID-Profile: Aravind Ganesh, Gordon A E Jewett, Ravinder-Jeet Singh, John H Wong

Zitieren

APA

Ganesh, A., Beland, B., Jewett, G. A. E., Campbell, D. J. T., Varma, M., Singh, R. J., Al-Sultan, A., Wong, J. H., & Menon, B. K. (2024). Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.28

Vancouver

Ganesh A, Beland B, Jewett GAE, Campbell DJT, Varma M, Singh RJ, et al. Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2024. doi:10.1017/cjn.2023.28

BibTeX
@article{Ganesh2024,
  author = {Ganesh, Aravind and Beland, Benjamin and Jewett, Gordon A E and Campbell, David J T and Varma, Malavika and Singh, Ravinder-Jeet and Al-Sultan, Abdulaziz and Wong, John H and Menon, Bijoy K},
  title = {Physician Approaches to Antithrombotic Therapies for Recently Symptomatic Carotid Stenosis},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2024},
  doi = {10.1017/cjn.2023.28}
}
Kostenlos starten →